Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meda has submitted Zyclara (imiquimod 3.75% cream) marketing authorization application (MAA) with the European Medicines Agency (EMA).
Subscribe to our email newsletter
Zyclara cream is indicated for the treatment of actinic keratosis (AK) on the face and scalp.
Meda CEO Anders Lonner said Zyclara will strengthen Meda’s dermatology franchise in Europe.
"We look forward to provide AK patients with a new product that can treat larger areas of the skin," Lonner said.
Zyclara cream is also used to treat genital warts that appear on the outside of the body.